Related Experiment Video
Updated: May 9, 2026
07:47
Isolation of Lung Retinoid-Containing Cells by Cell Sorting
Published on: April 11, 2025
Two faces of vitamin E in the lung
Joan M Cook-Mills1, Hiam Abdala-Valencia, Tina Hartert
1Allergy-Immunology Division, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. j-cook-mills@northwestern.edu
American Journal of Respiratory and Critical Care Medicine
|August 3, 2013
Summary
Vitamin E isoforms have opposing effects on allergic lung inflammation, impacting asthma risk. Understanding these vitamin E (tocopherol) interactions may explain global asthma prevalence variations.
Area of Science:
- Immunology
- Nutritional Science
- Environmental Health
Background:
- Asthma and allergic lung diseases result from complex gene-environment interactions.
- Dietary factors, like vitamin E, are implicated in asthma risk, but studies show conflicting results.
- Vitamin E, a group of tocopherol compounds, plays a role in immune responses.
Purpose of the Study:
- To explore the dual regulatory effects of vitamin E (tocopherol) isoforms on allergic lung inflammation.
- To investigate the mechanisms by which tocopherol isoforms modulate lung inflammation.
- To reconcile conflicting clinical study outcomes regarding vitamin E and asthma risk.
Main Methods:
- Review of existing literature on vitamin E isoforms and allergic lung inflammation.
- Analysis of proposed mechanisms for tocopherol isoform regulation of immune responses in the lungs.
- Examination of clinical study data associating vitamin E isoforms with asthma outcomes.
Main Results:
- Tocopherol isoforms exhibit opposing regulatory effects on allergic lung inflammation.
- Specific mechanisms for how vitamin E isoforms influence lung inflammation are discussed.
- Variations in global asthma prevalence may be partly explained by differing vitamin E isoform exposures.
Conclusions:
- The diverse effects of vitamin E isoforms are critical to understanding asthma pathogenesis.
- Further research into tocopherol isoform-specific actions is needed to clarify their role in allergic lung disease.
- Targeting vitamin E isoforms could offer new strategies for asthma prevention and treatment.
Related Concept Videos
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:26Alveoli and Alveolar Ducts
The respiratory zone of the human body, which stands in contrast to the conducting zone, comprises the structures that actively participate in the exchange of gases. The initiation of this zone is marked by the terminal bronchioles converging into respiratory bronchioles, the tiniest bronchiole classification. The respiratory bronchioles give way to the alveolar ducts that opens into a congregation of alveoli. Actively involved in gas exchange, alveoli resemble tiny sacs similar to clusters of...
01:31Lipid-derived Compounds in the Human Body
Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...